Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
Filed with BSE · · 3 pages · English
Summary by 6ix AI
This filing is a disclosure under SEBI regulations regarding a substantial acquisition of shares by a promoter of Lord's Mark Industries Limited. It reports that Mr. Sachidanand H. Upadhyay disposed of a significant number of equity shares through the open market. The document includes details of the shareholding before and after the transaction, indicating a reduction in the promoter's stake. The filing also provides the necessary regulatory information as required by SEBI guidelines.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Lord'S Mark Industries Limited on 6ix
Earlier from Lord'S Mark Industries
- Shareholder Meeting / Postal Ballot-Outcome of AGM
- Closure of Trading Window
- Intimation Titled 'From An Indian Innovation To A Global Renal-Care Opportunity: Lord'S Mark Industries Takes Its AI-Powered Dialysis Ecosystem Closer To International Markets'
- Intimation Regarding Confirmation And Proposal Received From Promoter, Mr. Sachidanand Hariram Upadhyay For Re-Investment Of Funds Received From Sale Of Equity Shares Of The Company For Medical Device Unit Expansion.
- Intimation Titled 'Technical Committee Approves Final Clinical Trial Stage; Company Targets Regulatory Clearances And Commercial Launch By April 2027'
Later from Lord'S Mark Industries
- Re-Investment Of Funds Received From Sale Of 89,98,598 Equity Shares By Promoter Mr. Sachidanand Hariram Upadhyay For Medical Device Unit Expansion Of The Company.
- Intimation Titled -Lord'S Mark Industries Limited Receives MHRA Registration For IVD Portfolio; UK Commercial Sales To Begin December 2026
- Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
- Announcement under Regulation 30 (LODR)-Acquisition
- Announcement under Regulation 30 (LODR)-Updates on Acquisition
Follow Lord'S Mark Industries into a list and get an email when it puts out news.
Follow Lord'S Mark Industries